c-Met/HDAC-IN-2 is a potent dual inhibitor of c-Met and HDAC, exhibiting anti-proliferative activity against several cancer cell lines; it induces G2/M cell cycle arrest and apoptosis in HCT-116 cells; it can be used in research on anticancer drug resistance.